Tampa, Florida
CNS clinical trials in Tampa, FL
70 CNS studies are recruiting participants at sites in Tampa as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Tampa at a glance
- 70 studies are recruiting at a site in Tampa.
- By phase: Phase 1 (1), Phase 2 (17), Phase 2/3 (2), Phase 3 (32), Phase 4 (3), No phase (9), Observational (6). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (63), university, hospital or other (7).
- By research area: Depression (23), Parkinson's Disease (13), Multiple Sclerosis (10), Migraine (9), Schizophrenia (7), Epilepsy (5), ADHD (3).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Tampa
Basic details from each study's public record (the 30 most recently updated of 70). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study sites
- Cenexel Tampa · Interventional Psychiatry of Tampa Bay
- Registry record
- NCT07226661 · updated
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Study site
- K2 Medical Research Tampa
- Registry record
- NCT06793397 · updated
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience
- Registry record
- NCT07002034 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Study site
- K2 Medical Research (Tampa)
- Registry record
- NCT07592689 · updated
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study site
- IPTB Clinical Research
- Registry record
- NCT07284667 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study sites
- IPTB Clinical Research · K2 Medical Research
- Registry record
- NCT03887715 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- K2 Medical Research - Tampa
- Registry record
- NCT07412756 · updated
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Interventional Psychiatry of Tampa Bay
- Registry record
- NCT05850689 · updated
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study sites
- Interventional Psychiatry of Tampa Bay · Psych Me Medical Research Inc
- Registry record
- NCT06559306 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- IPTB Clinical Research
- Registry record
- NCT07573176 · updated
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06966401 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Tampa, FL on ClinicalTrials.gov.
Schizophrenia studies recruiting in Tampa
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- Minerva Neurosciences
- Study site
- ForCare Clinical Research
- Registry record
- NCT07565428 · updated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- University of South Florida
- Registry record
- NCT06540833 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Tampa, FL on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Tampa
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- University of South Florida
- Registry record
- NCT02071134 · updated
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Observational
- All ages
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- University of South Florida
- Registry record
- NCT03664609 · updated
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
- Observational
- Ages 18 to 69
- All sexes
- Sponsor
- AbbVie
- Study site
- University of South Florida- Neuroscience Institute /ID# 278562
- Registry record
- NCT07227896 · updated
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Moffit Cancer Center ( Site 5026)
- Registry record
- NCT07216703 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- USF Parkinsons Disease and Movement Disorders Center
- Registry record
- NCT07174310 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- USF Parkinson's Disease and Movement Disorders Center
- Registry record
- NCT06944522 · updated
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Phase 2
- Ages 40 to 80
- All sexes
- Sponsor
- Neuron23 Inc.
- Study site
- USF Parkinson's & Movement Disorders Clinic
- Registry record
- NCT06680830 · updated
A Study of Buntanetap in Participants With PD
- Phase 2/3
- Ages 40 to 85
- All sexes
- Sponsor
- Annovis Bio Inc.
- Study site
- University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di
- Registry record
- NCT07284784 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Tampa, FL on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Tampa
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Study site
- University of South Florida Department of Neurology - MS Division
- Registry record
- NCT07299019 · updated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Study site
- University of South Florida Department of Neurology - MS Division
- Registry record
- NCT07067463 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Tampa, FL on ClinicalTrials.gov.
Epilepsy studies recruiting in Tampa
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
- Phase 2/3
- Ages 10 and older
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Study site
- Pediatric Epilepsy & Neurology Specialists
- Registry record
- NCT07723963 · updated
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Phase 3
- Ages 4 to 55
- All sexes
- Sponsor
- SK Life Science, Inc.
- Study site
- Pediatric Epilepsy and Neurology Specialists
- Registry record
- NCT05219617 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- University of South Florida
- Registry record
- NCT05667142 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Tampa, FL on ClinicalTrials.gov.
Migraine studies recruiting in Tampa
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- Vantage Clinical Trials
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Cenexel Tampa FL
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Tampa, FL on ClinicalTrials.gov.
Ask about studies near Tampa
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
225 studies recruiting across 72 cities.
Miami
82 studies recruiting.
Orlando
57 studies recruiting.
Jacksonville
39 studies recruiting.
Hollywood
33 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections